Review Article Modulation of cholesterol in midlife affords cognitive advantage during ageing – a role for altered redox balance
M. Cristina Polidori1, Ludger Pientka1, Gereon Nelles MD2, Helen R. Griffiths3
Department of Geriatrics, Marienhospital Herne, Ruhr University Bochum, Germany; Department of Neurology, St. Elisabeth- Krankenhaus Köln, Cologne, Germany; School of Health and Life Sciences, Aston University, Birmingham, UK
Received February 8, 2010, accepted March 26, 2010, available online March 30, 2010
Abstract: General practitioners, geriatricians, neurologists and health care professionals all over the world will be facing by 2040 the diagnostic, therapeutic and socioeconomic challenges of over 80 million people with dementia. Dementia is one of the most common diseases in the elderly which drastically affects daily life and everyday personal activities, is often associated with behavioural symptoms, personality change and numerous clinical complications and increases the risk for urinary incontinence, hip fracture, and – most markedly – the dependence on nursing care. The costs of care for patients with dementia are therefore immense. Serum cholesterol levels above 6.5 mmol/L are known to be associated with an increased RR of 1.5 and 2.1 to develop Alzheimer’s disease, the most common form of dementia, and a reduction of serum cholesterol in midlife is associated with a lowered dementia risk. The aim of this work is to critically discuss some of the main results reported recently in the literature in this respect and to provide the pathophysiological rationale for the control of dyslipidemia in the prevention of dementia onset and progression. (IJCEM1002004).